Technologies Overview is a topic within the NeuroWiki knowledge base covering aspects of neurodegenerative disease research and mechanisms.
This section covers technologies used in neurodegenerative disease research and treatment, spanning therapeutic interventions, diagnostic methods, and research tools. [@song2023]
Therapeutic Technologies
Gene Therapy
Gene therapy approaches deliver genetic material to modify disease processes. Key technologies include: [@baker2022]
Gene therapy for neurodegenerative diseases targets monogenic disorders and aims to deliver neuroprotective factors. Clinical trials are underway for Parkinson's, Alzheimer's, and ALS.
Neuromodulation
Neuromodulation uses electrical or chemical stimulation to modify neural activity:
[Deep Brain Stimulation (DBS)](/treatments/deep-brain-stimulation) — Implanted electrodes for Parkinson's, tremor
[Transcranial Magnetic Stimulation](/therapeutics/transcranial-magnetic-stimulation) — Non-invasive brain stimulation for cognitive enhancement
[Optogenetics](/technologies/optogenetics) — Light-based neural control (research stage)
[DREADDs](/technologies/dreads) — Chemogenetic control of neuronal activity
...
Overview
Technologies Overview is a topic within the NeuroWiki knowledge base covering aspects of neurodegenerative disease research and mechanisms.
This section covers technologies used in neurodegenerative disease research and treatment, spanning therapeutic interventions, diagnostic methods, and research tools. [@song2023]
Therapeutic Technologies
Gene Therapy
Gene therapy approaches deliver genetic material to modify disease processes. Key technologies include: [@baker2022]
Gene therapy for neurodegenerative diseases targets monogenic disorders and aims to deliver neuroprotective factors. Clinical trials are underway for Parkinson's, Alzheimer's, and ALS.
Neuromodulation
Neuromodulation uses electrical or chemical stimulation to modify neural activity:
[Deep Brain Stimulation (DBS)](/treatments/deep-brain-stimulation) — Implanted electrodes for Parkinson's, tremor
[Transcranial Magnetic Stimulation](/therapeutics/transcranial-magnetic-stimulation) — Non-invasive brain stimulation for cognitive enhancement
[Optogenetics](/technologies/optogenetics) — Light-based neural control (research stage)
[DREADDs](/technologies/dreads) — Chemogenetic control of neuronal activity
DBS is clinically approved for Parkinson's disease and essential tremor. TMS shows promise for Alzheimer's and depression.
Drug Delivery
Effective CNS drug delivery remains challenging due to the [blood-brain barrier](/entities/blood-brain-barrier):
[Blood-Brain Barrier Crossing](/technologies/bbb-crossing) — Strategies including Trojan horses, focused ultrasound
[Nanoparticle Delivery](/technologies/nanoparticle-delivery) — Targeted nanoparticles for drug transport
[Intranasal Delivery](/technologies/intranasal-delivery) — Non-invasive CNS delivery via nasal passages
[Convection-Enhanced Delivery](/therapeutics/convection-enhanced-delivery) — Direct infusion into brain tissue
Diagnostic Technologies
Imaging
Neuroimaging provides structural and molecular information:
[PET Imaging](/technologies/pet-imaging) — Molecular imaging for amyloid, [tau](/proteins/tau), dopamine
[MRI Technologies](/technologies/mri-technologies) — Structural, functional, and diffusion imaging
[Optical Imaging](/technologies/optical-imaging) — Fluorescence and two-photon imaging
Biomarker Detection
Sensitive detection enables early diagnosis:
[Simoa Technology](/technologies/simoa) — Ultra-sensitive immunoassays for p-tau, [NfL](/biomarkers/neurofilament-light-chain-nfl)
[Seed Amplification Assay](/technologies/seed-amplification) — Detection of misfolded proteins
[Mass Spectrometry](/technologies/mass-spectrometry) — Proteomics and metabolomics
Research Technologies
Stem Cell Technologies
[iPSC Disease Models](/technologies/ipsc-disease-models) — Patient-derived [neurons](/entities/neurons) for disease modeling
[Brain Organoids](/technologies/brain-organoids) — 3D brain tissue cultures
Omics Technologies
[Single-Cell Genomics](/technologies/single-cell-genomics) — Cell-type specific analysis
[Spatial Transcriptomics](/technologies/spatial-transcriptomics) — Gene expression with spatial context
[Proteomics](/technologies/proteomics) — Large-scale protein analysis
Structural Biology
[Cryo-Electron Microscopy](/technologies/cryo-electron-microscopy) — Atomic resolution protein structures
[X-ray Crystallography](/technologies/xray-crystallography) — Protein structure determination
Technology Rankings
See [Technology Rankings](/technologies/rankings) for a ranked list by therapeutic potential and development stage.
Technology Integration
Modern neurodegenerative disease research increasingly combines multiple technologies:
Multi-Omics Integration
Combining genomics, transcriptomics, proteomics, and metabolomics provides comprehensive disease understanding. Single-cell approaches reveal cell-type specific changes impossible to detect in bulk tissue.
Imaging and Biomarker Correlation
Linking PET amyloid/tau imaging with CSF and plasma biomarkers enables validation of fluid biomarkers against ground-truth imaging. This accelerates biomarker development and clinical qualification.
Disease Modeling
iPSC-derived neurons from patient samples enable disease modeling with human genetics. Combined with CRISPR editing, isogenic cell lines reveal mutation-specific effects.
Future Directions
The technology landscape continues evolving:
Spatial Biology: Mapping molecular changes within intact tissue architecture
Proteomics: Next-gen proteomics identifying thousands of proteins
Neural Interfaces: High-density electrode arrays for circuit mapping
AI/ML: Deep learning for image analysis, biomarker discovery, patient stratification
Allen Brain Atlas API for Neurodegeneration Workflows
AllenSDK in Neurodegeneration Research
AlphaFold for Neurodegenerative Diseases
Antisense Oligonucleotide Therapy in Neurodegeneration
Artificial Intelligence for Neurodegeneration Research
Artificial Intelligence in Neurodegeneration Research
BCI Clinical Trials for Neurodegenerative Diseases
BCI Clinical Trials for Neurodegenerative Diseases
BCI for Alzheimer's Disease
BCI for FTD Behavioral Circuit Modulation
BCI for Multiple Sclerosis
BCI-Assisted Rehabilitation
Biointegrated Neural Interfaces
Bitbrain Brain-Computer Interface
Blackrock Neurotech
Blackrock Neurotech — Brain-Computer Interface
Brain Knowledge Platform
Brain Organoid-Silicon Interface Technology
Brain Organoids
Brain Organoids for Neurodegeneration Research
Brain-Computer Interface Technologies
Brain-Computer Interface Technologies
Brain-Computer Interface Technology
Brain-Computer Interface Technology Landscape
Brain-Computer Interface for Frontotemporal Dementia
Brain-Computer Interface for Huntington's Disease
See all 107 technologies pages...
References
[@song2023]: Song P. AAV gene therapy for neurological disorders. Nature Reviews Drug Discovery. 2023. [@baker2022]: Baker M. Next-generation CRISPR technologies. Nature Methods. 2022.